Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1363020Generated: October 26, 2026

Sodium Iodide → 6-Butyl-8-({1-[3-(methylsulfonyl)propyl]-4-piperidinyl}oxy)quinoline, dihydrochloride salt

https://huagongshe.com/reaction/1363020

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium IodideHCID 5238—
ReactantSodium BicarbonateHCID 516892—
Reactant1-Chloro-3-methanesulfonylpropaneHCID 13875042—
Reactant1-Bromo-3-methanesulfonylpropaneHCID 51892082—
Reactant6-Butyl-8-(4-piperidinyloxy)quinolineHCID 57926048—
SolventMethanolHCID 887—
SolventDimethylformamideHCID 6228—
Product6-Butyl-8-({1-[3-(methylsulfonyl)propyl]-4-piperidinyl}oxy)quinoline, dihydrochloride saltHCID 13172865118%

Reaction Conditions

Temperature150 °C

Reaction Steps

A mixture of 6-butyl-8-(4-piperidinyloxy)quinoline (for example, as prepared for Intermediate 4) (80 mg, 0.28 mmol), sodium iodide (30 mg, 0.2 mmol) and sodium bicarbonate (110 mg, 1.3 mmol) in DMF (2 ml) was treated with a solution of mixture of 3-bromopropyl methyl sulfone and 3-chloropropyl methyl sulfone (for example, as prepared for Intermediate 19) (124 mg) in DMF (0.5 ml) and the mixture was heated at 150° C. for 15 min in a Smith Creator™ microwave oven. The reaction mixture was applied to an SCX-2 cartridge (10 g), preconditioned with methanol, and eluted with methanol, followed by 10% aqueous 0.88 s.g. ammonia in methanol. The ammoniacal fractions were combined and concentrated in vacuo and the residue (126 mg) was purified by MDAP. Appropriate fractions were combined and concentrated in vacuo and the residue (30 mg) was applied to an SCX-2 cartridge (5 g), pre-conditioned with methanol and eluted with methanol, followed by 10% aqueous 0.88 s.g. ammonia in methanol. The ammoniacal fractions were combined and concentrated in vacuo to give the free base of the title compound (21 mg, 18%): This was treated with 1.25 M hydrogen chloride solution in methanol (0.15 ml) and the solution was evaporated in vacuo to give the title compound (22 mg, 89%): LCMS RT=2.49 min, ES+ve m/z 405 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07884114B2
Source datasetuspto-grants-2011_02
ORD IDord-60a9677521dc4467879e6d15d97e4813
Source noteuspto-grants-2011_02